INTERNATIONAL PATENT: INSTITUTO BUTANTAN FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION COMPRISING MITOGENS AND STRESS CONTROL PATHWAY INHIBITORS FOR THE TREATMENT OF CANCER"

GENEVA, Oct. 3 -- INSTITUTO BUTANTAN (Avenida Vital Brasil, 1500 - Butantã05503-900 São Paulo, SP) filed a patent application (PCT/BR2025/050117) for "PHARMACEUTICAL COMPOSITION COMPRISING MITOGENS AND STRESS CONTROL PATHWAY INHIBITORS FOR THE TREATMENT OF CANCER" on Mar 28, 2025. With publication no. WO/2025/199602, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ARMELIN, Hugo, Aguirre (Rua Casa do Ator, 59304546-002 São Paulo, SP), MOREIRA, Rosangela Aparecida, Wailemann (Av. Souza Bandeira, 363, Jardim S...